Status:
WITHDRAWN
Palliative Care Consultation to Improve Communication for Patients Considering Surgery for a Pancreatic Neoplasm
Lead Sponsor:
Fred Hutchinson Cancer Center
Conditions:
Pancreatic Neoplasm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial evaluates a palliative care consultation for improving communication between providers and patients considering surgery for a pancreatic neoplasm. Pancreatic operations have known ...
Detailed Description
OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients receive usual care and undergo evaluation by a tumor board within 14 days of baseline. ARM II: Patients attend a palliative care visi...
Eligibility Criteria
Inclusion
- Adults (18 years or older)
- Pancreatic neoplasm pathology
- Ability to read, write, and speak in English
- Has decisional capacity
- Expected to be seen and discussed at PCSC and seeing a surgeon as part of their tumor board evaluation
Exclusion
- Metastatic pancreatic neoplasm
- Currently incarcerated
- Currently is or previously has received palliative care, or are unwilling to forego palliative care for the first 90 days post randomization
- Evidence of any behavior, condition, or circumstance (including, but not limited to: blindness, deafness, serious behavior or mental health conditions, discontinuing curative treatment, lack of access to technology, etc) that would interfere with their ability to complete study procedures as noted within the chart
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2026
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06545344
Start Date
September 1 2025
End Date
January 1 2026
Last Update
June 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States, 98109